Free Trial
NYSE:RFL

Rafael Q2 2026 Earnings Results & Report

Rafael logo
$1.46 +0.03 (+1.96%)
Closing price 03:59 PM Eastern
Extended Trading
$1.46 +0.00 (+0.14%)
As of 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rafael reported Q2 2026 earnings on March 16, 2026. The company reported EPS of -$0.13, while revenue was $0.21 million.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

Rafael EPS Results

Actual EPS
-$0.13
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Rafael Revenue Results

Actual Revenue
$0.21 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Rafael's Q4 2026 earnings is estimated for Wednesday, October 28, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, October 27, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Rafael Q2 2026 Earnings FAQ

Rafael (NYSE:RFL) reported earnings of -$0.13 per share for Q2 2026. The report was announced on Monday, March 16, 2026.

Rafael reported revenue of $0.21 million for Q2 2026.

Rafael's next earnings date is estimated for Wednesday, October 28, 2026. MarketBeat tracks confirmed and estimated earnings dates for Rafael on the company's earnings history page.

Rafael Earnings Headlines

Contrasting Rafael (NYSE:RFL) and Innoviva (NASDAQ:INVA)
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel
Reviewing Rafael (NYSE:RFL) & vTv Therapeutics (NASDAQ:VTVT)
See More Rafael Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rafael? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rafael and other key companies, straight to your email.

About Rafael

Rafael (NYSE:RFL) is a diversified holding company focused primarily on life sciences and real estate. Through its life sciences activities, the company has supported the development of therapies designed to address serious diseases, including cancer, with a particular emphasis on treatments that target cancer-cell metabolism.

The company’s real estate interests include commercial properties and related investments. Rafael Holdings has historically maintained a connection to Rafael Pharmaceuticals, a biotechnology company involved in oncology drug development, although its operating structure and investments may change over time.

Rafael Holdings was established as a spin-off from IDT Corporation. The company is based in the United States and serves its markets through its investment holdings rather than through a broad consumer-facing product portfolio.

View Rafael Profile